Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Zivo Bioscience Inc. (ZIVO:NASDAQ), powered by AI.
Zivo Bioscience Inc. is currently trading at $2.07. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Zivo Bioscience Inc. on Alpha Lenz.
Zivo Bioscience Inc.'s P/E ratio is -0.5.
“Zivo Bioscience Inc. trades at a P/E of -0.5 (undervalued) with strong ROE of 983.9%.”
Ask for details →Zivo Bioscience Inc. is a research and development company specializing in biotechnology, with a focus on leveraging proprietary algal and bacterial strains to create innovative nutritional compounds and bioactive molecules. The company's core operations center around the study, development, and commercialization of naturally derived ingredients targeting both human and animal health. Zivo Bioscience actively develops and licenses intellectual property, including unique algae cultures, extracts, and patented or patent-pending product concepts. Its primary fields of application include human dietary supplements, nutraceuticals, food ingredients, and animal feed additives, with projects addressing areas such as poultry gut health, bovine mastitis, canine joint health, and human immune modulation. Operating across both the biotech and agtech sectors, Zivo’s business model is heavily based on licensing its technology and selling specialized bioactive compounds to manufacturers in the nutrition, supplement, and medical food industries, emphasizing the growing market demand for natural, functional ingredients.
“Zivo Bioscience Inc. trades at a P/E of -0.5 (undervalued) with strong ROE of 983.9%.”
Ask for details →Zivo Bioscience Inc. (ticker: ZIVO) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 7 employees. Market cap is $7M.
The current price is $2.07 with a P/E ratio of -0.49x and P/B of -12.73x.
ROE is 983.91% and operating margin is -8498.85%. Annual revenue is $157,220.